Dalriada aims for net zero pension schemes by 2040 where it is sole-trustee

James Phillips
clock • 3 min read
Dalriada is targeting net zero across its trustee schemes by 2040
Image:

Dalriada is targeting net zero across its trustee schemes by 2040

Firm also sets out plans to push for climate action on pension schemes where it acts as a co-trustee

Dalriada Trustees has set out plans to slash carbon emissions to net zero within the portfolios of pension schemes where it acts as sole trustee by 2040. With interim targets of a 25 per cent reduction...

To continue reading this article...

Join BusinessGreen

In just a few clicks you can start your free BusinessGreen Lite membership for 12 months, providing you access to:

  • Three complimentary articles per month covering the latest real-time news, analysis, and opinion from Europe’s leading source of information on the Green economy and business
  • Receive important and breaking news stories via our daily news alert
  • Our weekly newsletter with the best of the week’s green business news and analysis

Join now

 

Already a BusinessGreen member?

Login

More on Investment

National Wealth Fund provides £300m loan guarantee to Haweswater Aqueduct Resilience Programme

National Wealth Fund provides £300m loan guarantee to Haweswater Aqueduct Resilience Programme

Rachel Reeves hails deal as evidence of how new government-backed fund is catalysing investment and enhancing climate resilience

James Murray
clock 22 August 2025 • 2 min read
Survey: Younger people leading drive towards greener pensions

Survey: Younger people leading drive towards greener pensions

OVO-commissioned study reveals under 35s are nearly three times more likely than those over 65 to know exactly where their pension is invested

BusinessGreen staff
clock 21 August 2025 • 2 min read
Meatable acquires Uncommon's cultivated meat platform

Meatable acquires Uncommon's cultivated meat platform

Lab grown meat pioneer pledges to progress and scale up Uncommon Bio's alternative protein innovation, after Cambridge-based firm shifts focus to therapeutic products

Stuart Stone
clock 21 August 2025 • 4 min read